Around 160,000 people in England have chronic hepatitis C, a preventable and treatable blood-borne virus that can lead to potentially fatal cirrhosis or cancer of the liver if left untreated. However, barriers to diagnosis, effective referral and treatment mean that many of these people are undiagnosed, and an increasing number are developing potentially fatal end stage liver disease.
Resources
Drug services professional
Around half of current injecting drug users will have hepatitis C, although this prevalence rate varies across the country. Find here tools, resources and other relevant documents to help drugs service staff raise awareness of hepatitis C amongst service users, and improve testing and access to care.
Showing 181 to 190 of 193 resources
-
The Uncomfortable Truth. Hepatitis C in England: The State of the Nation
England Oct 2013 Reports & Research PDF -
Together for Health -Liver Disease Delivery Plan
The Liver Disease Delivery Plan, launched by the Welsh Government and NHS Wales in May 2015, seeks to prevent liver disease and improve related services, and includes a focus on addressing viral hepatitis in Wales.
The Plan aims to halt the ride in liver disease and deaths; provide more support to patients; improve the quality of services' improve specialist knowledge in liver disease throughout the health service, and encourage patients to take responsibility for their health and care.UK, Wales May 2015 Other, Strategy & Planning PDF -
Together for Health: Liver Disease Annual Report 2016 - Setting the Baseline
This report, published by the Welsh Government and NHS Wales, provides an overview of liver disease in Wales, and gives details of the actions currently underway to tackle liver disease, including hepatitis C.UK, Wales Reports & Research PDF -
Treatment Guidance for Patients with Hepatitis C in Greater Manchester
This document provides guidance on treatment for patients with Hepatitis C in Greater Manchester. It defines responses to treatment, runs through treatment protocols, types of treatment for various kinds of patient, and protocols for managing treatment side effects.North West 04 Nov 2010 Reports & Research, Tools & Templates PDF -
Tri-borough Substance Misuse and Sexual Health Blood Borne Virus Strategy 2014-2016: Hammersmith & Fulham, Royal Borough of Kensington & Chelsea, and Westminster City Council
This substance misuse and sexual health blood borne virus strategy has been produced jointly by the tri-borough of Hammersmith and Fulham, the Royal Borough of Kensington and Chelsea and Westminster City Council to ensure that prevention, diagnosis and treatment of hepatitis C has an increased focus.Greater London Jul 2014 Strategy & Planning PDF -
Turning Evidence into Practice: Improving access to, and completion of, hepatitis C treatment
This briefing, produced by Public Health England, has practical advice for commissioners and services on improving access to, and completion of, hepatitis C treatment. It provides an overview of the key local issues that local providers and commissioners of drug and hepatitis C treatment should consider when commissioning and delivering services, and contains a series of prompts and examples of good practice.UK, England Jul 2015 Case study, Tools & Templates, Strategy & Planning PDF -
Understanding the pathway: barriers to data collection and onward referral to specialist hepatitis C services for PWID in London
This report, from the London Joint Working Group on Substance Use and Hepatitis C, examines barriers to data collection and onward referral to specialist hepatitis C services for people who inject drugs in London.England, Greater London Reports & Research PDF -
Unlinked anonymous HIV and viral hepatitis monitoring among PWID: 2017 report
This report presents an overview of the trends between 2006 and 2016 for HIV, hepatitis B, hepatitis C and risk behaviours from the ongoing Unlinked Anonymous Monitoring Survey, which is targeted at people who inject psychoactive drugs, such as heroin, crack cocaine and amphetamines.UK Reports & Research PDF -
Wirral Drug and Alcohol Addiction Team (DAAT) Hep C Strategy
The National Treatment Agency’s (NTA) aspirational target is for each DAAT partnership to ensure that 100% of their previous/current injecting drug user (IDU) population to have been tested for Hepatitis C. Many DAATs across the country have struggled to achieve this target and Wirral DAAT’s performance at the end of 2007/08 is at 20%.North West 2011 Case study, Strategy & Planning PDF -
Working Together to Reduce Harm (Substance Misuse) Delivery Plan 2016 - 2018
This Welsh Government delivery plan describes the work that will be undertaken reduce the harm caused by substance misuse. It includes actions related to hepatitis C such as the implementation of routine opt-out testing in substance misuse services.UK, Wales Sep 2016 Strategy & Planning PDF